Risultati della ricerca - Schattenberg, Jörn M.

Emerging Pharmacological Treatment in Nonalcoholic Steatohepatitis di Schattenberg, Jörn M

Testo Testo Testo

The Gut Microbiome and Nonalcoholic Steatohepatitis di Schattenberg, Jörn M.

Testo Testo

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD) di Schattenberg, Jörn M., Bergheim, Ina

Testo Testo Testo

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers di Schattenberg, Jörn M., Ekstedt, Mattias

Testo Testo Testo

Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches di Armandi, Angelo, Schattenberg, Jörn M.

Testo Testo Testo

Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic? di Schattenberg, Jörn M., Emrich, Tilman

Testo Testo Testo

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling di Schattenberg, Jörn M., Czaja, Mark J.

Testo Testo Testo

Liver injury in COVID-19: The current evidence di Alqahtani, Saleh A, Schattenberg, Jörn M

Testo Testo Testo

Nonalcoholic Fatty Liver Disease in 2020 di Maher, Jacquelyn J., Schattenberg, Jörn M.

Testo Testo Testo

NAFLD in the Elderly di Alqahtani, Saleh A, Schattenberg, Jörn M

Testo Testo Testo

The unmet need of personalized HCC screening—Lessons learned from the Swedish nationwide registries di Gairing, Simon Johannes, Schattenberg, Jörn M.

Testo Testo Testo

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass? di Noureddin, Nabil, Schattenberg, Jörn M., Alkhouri, Naim, Noureddin, Mazen

Testo Testo Testo

Chronic oxidative stress sensitizes hepatocytes to death from 4-hydroxynonenal by JNK/c-Jun overactivation di Singh, Rajat, Wang, Yongjun, Schattenberg, Jörn M., Xiang, Youqing, Czaja, Mark J.

Testo Testo Testo

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany di Labenz, Christian, Kostev, Karel, Kaps, Leonard, Galle, Peter R., Schattenberg, Jörn M.

Testo Testo Testo

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany di Labenz, Christian, Kostev, Karel, Armandi, Angelo, Galle, Peter R., Schattenberg, Jörn M.

Testo Testo Testo

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD) di Nier, Anika, Huber, Yvonne, Labenz, Christian, Michel, Maurice, Bergheim, Ina, Schattenberg, Jörn M.

Testo Testo Testo

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease di van Dijk, Anne‐Marieke, Schattenberg, Jörn M., Holleboom, Adriaan G., Tushuizen, Maarten E.

Testo Testo Testo

Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders di Gairing, Simon Johannes, Galle, Peter Robert, Schattenberg, Jörn M., Kostev, Karel, Labenz, Christian

Testo Testo Testo

Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany di Tilch, Marie-Kristin, Galle, Peter R., Schattenberg, Jörn M., Kostev, Karel, Labenz, Christian

Testo Testo Testo

Non-alcoholic fatty liver disease increases the risk of incident chronic kidney disease di Kaps, Leonard, Labenz, Christian, Galle, Peter R, Weinmann-Menke, Julia, Kostev, Karel, Schattenberg, Jörn M

Testo Testo Testo